271 related articles for article (PubMed ID: 34037665)
1. Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis.
Sturm AC; Truty R; Callis TE; Aguilar S; Esplin ED; Garcia S; Haverfield EV; Morales A; Nussbaum RL; Rojahn S; Vatta M; Rader DJ
JAMA Cardiol; 2021 Aug; 6(8):902-909. PubMed ID: 34037665
[TBL] [Abstract][Full Text] [Related]
2. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
[TBL] [Abstract][Full Text] [Related]
4. Expanding the genetic spectrum for Chinese familial hypercholesterolemia population with six genetic mutations identified using a next-generation sequencing-based laboratory-developed screening test.
Jingxin S; Shitong C
Mol Genet Genomic Med; 2022 Dec; 10(12):e2070. PubMed ID: 36226792
[TBL] [Abstract][Full Text] [Related]
5. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
[TBL] [Abstract][Full Text] [Related]
6. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
[TBL] [Abstract][Full Text] [Related]
7. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
[TBL] [Abstract][Full Text] [Related]
8. Molecular screening of familial hypercholesterolemia in Icelanders.
Kellogg G; Thorsson B; Cai Y; Wisotzkey R; Pollock A; Akana M; Fox R; Jansen M; Gudmundsson EF; Patel B; Chang C; Jaremko M; Puig O; Gudnason V; Emilsson V
Scand J Clin Lab Invest; 2020 Oct; 80(6):508-514. PubMed ID: 32706999
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
Horton C; Hoang L; Zimmermann H; Young C; Grzybowski J; Durda K; Vuong H; Burks D; Cass A; LaDuca H; Richardson ME; Harrison S; Chao EC; Karam R
JAMA Oncol; 2024 Feb; 10(2):212-219. PubMed ID: 37924330
[TBL] [Abstract][Full Text] [Related]
10. Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.
Alnouri F; Al-Allaf FA; Athar M; Abduljaleel Z; Alabdullah M; Alammari D; Alanazi M; Alkaf F; Allehyani A; Alotaiby MA; Alshehri A; Bouazzaoui A; Karrar H; Taher MM
Glob Heart; 2020 Feb; 15(1):19. PubMed ID: 32489792
[TBL] [Abstract][Full Text] [Related]
11. Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement.
Di Taranto MD; Giacobbe C; Palma D; Iannuzzo G; Gentile M; Calcaterra I; Guardamagna O; Auricchio R; Di Minno MND; Fortunato G
Clin Genet; 2021 Nov; 100(5):529-541. PubMed ID: 34297352
[TBL] [Abstract][Full Text] [Related]
12. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
[TBL] [Abstract][Full Text] [Related]
13. Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study.
Norsworthy PJ; Vandrovcova J; Thomas ER; Campbell A; Kerr SM; Biggs J; Game L; Soutar AK; Smith BH; Dominiczak AF; Porteous DJ; Morris AD; Scotland G; Aitman TJ
BMC Med Genet; 2014 Jun; 15():70. PubMed ID: 24956927
[TBL] [Abstract][Full Text] [Related]
14. Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.
Reeskamp LF; Balvers M; Peter J; van de Kerkhof L; Klaaijsen LN; Motazacker MM; Grefhorst A; van Riel NAW; Hovingh GK; Defesche JC; Zuurbier L
Atherosclerosis; 2021 Mar; 321():14-20. PubMed ID: 33601267
[TBL] [Abstract][Full Text] [Related]
15. Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults.
Bellows BK; Khera AV; Zhang Y; Ruiz-Negrón N; Stoddard HM; Wong JB; Kazi DS; de Ferranti SD; Moran AE
J Am Heart Assoc; 2022 Jun; 11(11):e025192. PubMed ID: 35583136
[TBL] [Abstract][Full Text] [Related]
16. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
17. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
Hooper AJ; Burnett JR; Bell DA; Watts GF
Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report.
Gratton J; Humphries SE; Futema M
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1737-1742. PubMed ID: 37409534
[TBL] [Abstract][Full Text] [Related]
19. Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.
Jordan E; Kinnamon DD; Haas GJ; Hofmeyer M; Kransdorf E; Ewald GA; Morris AA; Owens A; Lowes B; Stoller D; Tang WHW; Garg S; Trachtenberg BH; Shah P; Pamboukian SV; Sweitzer NK; Wheeler MT; Wilcox JE; Katz S; Pan S; Jimenez J; Fishbein DP; Smart F; Wang J; Gottlieb SS; Judge DP; Moore CK; Mead JO; Hurst N; Cao J; Huggins GS; Cowan J; Ni H; Rehm HL; Jarvik GP; Vatta M; Burke W; Hershberger RE;
JAMA; 2023 Aug; 330(5):432-441. PubMed ID: 37526719
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
